A multifunctional T-cell engager containing CD80 enhances prostate cancer treatment
Abstract Background T-cell engagers (TCEs), the most extensively studied class of bispecific antibodies, redirect effector T cells to tumor cells to induce immune synapse formation, T-cell activation, and subsequent tumor cell killing. However, their therapeutic efficacy in solid tumors is limited b...
Saved in:
| Main Authors: | Disen Nie, Yao Jiang, Hui Li, Keying Zhang, Zhengxuan Li, Tong Lu, Yu Li, Donghui Han, Changhong Shi, Nianzeng Xing, Fa Yang, Weihong Wen, Weijun Qin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Cancer Immunology, Immunotherapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00262-025-04121-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immuno-histochemical research of microvasculation in human prostate gland in an early postnatal ontogenesis
by: V. M. Yevtushenko
Published: (2014-06-01) -
Association of CD24, CD27, and co-stimulatory molecules CD80 immunological marker expression on B-cells of human peripheral blood with development of celiac disease
by: Rahab Abd-Ali Al-Madany, et al.
Published: (2024-12-01) -
Research progress of CD80 in the development of immunotherapy drugs
by: Lanying Li, et al.
Published: (2024-11-01) -
Which PSMA PET/CT interpretation criteria most effectively diagnose prostate cancer? a retrospective cohort study
by: Le Ma, et al.
Published: (2025-01-01) -
Corrigendum: Research progress of CD80 in the development of immunotherapy drugs
by: Lanying Li, et al.
Published: (2024-12-01)